Browse Health Policy Project (2010-2016) Materials
- Advocacy
- Best Practices
- Capacity Development
- Child Protection
- Civil Society Engagement
- Contraceptive Security
- Costed Implementation Plan
- Costing
- Demographic Dividend
- Efficiency & Effectiveness
- Equity
- Family Planning/Reproductive Health
- FP2020
- Gender
- Gender-based Violence
- GeoHealth Mapping
- Governance, Stewardship & Accountability
- Health Financing
- Health Systems Strengthening
- HIV
- ImpactNow
- Integration
- Leadership
- Malaria
- Maternal Health
- Men having Sex with Men
- Millennium Development Goals
- Modeling
- Monitoring & Evaluation
- Non-Government/Community Service Org.
- OneHealth
- Orphans and Vulnerable Children
- Other Health Domains
- Parliamentarians
- People Living With HIV
- People who Inject Drugs
- Policy
- Private Sector
- RAPID
- Religious Leaders/FBOs
- Repositioning Family Planning
- Scale-up
- Sex Workers
- Spectrum
- Stakeholder Engagement
- Stigma and Discrimination
- Sustainable Financing
- Transgender
- Universal Health Coverage
- Urban and Rural Poor
- Women
- Youth
- GAP Tool
- MDG Briefs
- Nigeria Health Financing Conference
- Nigeria RAPID
- Respectful Maternity Care
- Stigma Package
- Ghana RAPID
- OCA Suite of Tools
- CIP Resource Kit
- Central Asian Republics
- Côte d'Ivoire
- Dominican Republic
- E&E
- Ethiopia
- Ghana
- Global
- Guatemala
- Haiti
- India
- Jamaica
- Jordan
- Kenya
- LAC
- Madagascar
- Malawi
- Mali
- Mozambique
- Nepal
- Nigeria
- Russia
- South Africa
- Tanzania
- Uganda
- Ukraine
- West Africa
- Zambia
- Zimbabwe
Country and regional assignments reflect those made at the time of production and may not correspond to current USAID designations.
Files will load from www.healthpolicyproject.com.
List entries are alphabetical by title and contain the title, abstract, and then the filename which is hyperlinked and will open in a new browser window. Most files are PDFs. There may be multiple files per abstract.
Specific
The government of Cote d'Ivoire is committed to the fight to gain control and turn the tide of the HIV epidemic. Striving to offer the best standard of HIV treatment, the country aims to adopt the new 90-90-90 target. The country also plans to roll out “test and offer” for the general population in the near future and begin piloting Option B+ for pregnant women in 2015. Such an intense scale-up of HIV treatment services will require intensified coordination to mobilize resources and effectively target those funds for treatment scale-up and sustainability.
The aim of this cost-outcome analysis study was to estimate the cost of HIV treatment scale-up and the impact of such an expansion by estimating the cost of treatment for one person per year for adults, children, and pregnant women. Currently, limited data exist around the unit cost of HIV treatment in Cote d’Ivoire. To inform policy decisions on how best to finance scale-up of treatment with the limited resources available, understanding the outcome of HIV treatment—and the levers for improving the chances of successful treatment—is critical.
The study found that the cost of the full year of treatment expected by following the national treatment guideline would be CFA142,431 (US$288) for adults, CFA217,603 (US$440) for children, CFA85,063 (US$172) for PMTCT Option B, and CFA 151,827 (US$207) for PMTCT Option B+. A total investment of approximately CFA147 billion (US$297 million) is required over the next five years, leading up to the year 2020, to achieve the 90-90-90 target and a 100 percent roll-out of the Option B+ approach for the prevention of mother-to-child transmission (PMTCT). This investment will save more than 35,000 lives and prevent more than 6,000 children from becoming infected via PMTCT compared to the status quo, in which treatment coverage increases at the historical pace.
- Côte d’Ivoire ART Costing Report (English) 779_FINALFuturesHPPCIARTCostingReport.pdf 7550.96 kb
- Côte d’Ivoire ART Costing Report (French) 779_FINALHPPCIARTCostingFrench.pdf 7560.22 kb